Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
National
Maggie Fick

Weight-loss war heats up as Wegovy rival found to lead to faster and greater results

Novo Nordisk

Support truly
independent journalism

Shares in Novo Nordisk, the company behind obesity drug Wegovy were down 1.1% on Tuesday after data analysis showing a rival treatment leads to faster and greater weight loss.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.